Trial intelligence / Profile preview

Rotigotine vs Ropinirole in early-stage Parkinson's Disease

NCT00243971Phase 3Completed

Sponsor
UCB
Start
Nov 2004
Primary completion
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Nov 2004; status: completed.

02

Drugs

rotigotine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00243971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00243971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call